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Complete Genome Sequence of emm Type 14 Streptococcus pyogenes
Strain HSC5
Gary C. Port, Elyse Paluscio, Michael G. Caparon
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA

Streptococcus pyogenes causes a greater diversity of human disease than any other bacterial pathogen. Here, we present the complete genome sequence of the emm type 14 S. pyogenes strain HSC5. This strain is a robust producer of the cysteine protease
SpeB and is capable of producing infection in several different animal models.
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S

treptococcus pyogenes is an important Gram-positive human
pathogen capable of causing a wide range of diseases, ranging
from mild superficial skin and throat infections (impetigo and
“strep throat”) to more-severe invasive diseases, including cellulitis and necrotizing fasciitis, as well as numerous postinfection
sequelae, including acute rheumatic fever and poststreptococcal
glomerulonephritis (1). As a strict human pathogen with no environmental or animal reservoirs, there is no single animal model
that entirely replicates the diversity of human diseases caused by
S. pyogenes. Consequently, several different animal models have
been developed that mimic particular aspects of S. pyogenes pathogenesis. The emm type 14 S. pyogenes strain HSC5 (2) is capable of
causing robust and highly reproducible infections in multiple animal models, including a necrotizing fasciitis (myositis) model of
infection in zebrafish (Danio rerio) (3) and several distinct mouse
models, including a self-resolving subcutaneous ulcer model
(4), a lethal systemic infection following intraperitoneal injection, and a recently described asymptomatic murine mucosal
carriage model (5).
One of the most well-studied secreted virulence factors produced by S. pyogenes is the cysteine protease SpeB, which is abundantly produced in many strains and is subject to multiple layers
of regulation (6). HSC5 has proven to be an exquisitely sensitive
SpeB indicator strain, as mutagenesis experiments in HSC5 have
revealed several novel SpeB regulators (7–10). Furthermore, studies on HSC5 have provided numerous insights into the fundamental aspects of protein secretion in S. pyogenes, including the
role of the signal recognition particle (SRP) pathway (11) and the
ExPortal protein secretion microdomain (12). We therefore
sought to determine the complete genome sequence of HSC5, the
first emm type 14 strain to be sequenced, in order to provide a
framework for future genetic studies on this versatile strain.
Genomic DNA from HSC5 was purified by phenolchloroform extraction (13) and sequenced using a 454 GS FLX
sequencer (MOgene LC, St. Louis, MO) by collecting shotgun
reads and 8-kb paired-end reads. A total of 202,164 reads
(64,290,146 nucleotides) were generated, reaching a depth of 35fold genome coverage. Sequences were assembled using Newbler
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v2.5.3. A total of 26 contigs were assembled and aligned to the
S. pyogenes strain SF370 genome, generating a single scaffold that
was 96% complete. The 26 remaining gaps (ranging from 0.5 kb to
16 kb, for a total of 70 kb) were filled in by primer walking (IDT,
Coralville, IA) and Sanger sequencing (GENEWIZ, South Plainfield, NJ). To correct any sequencing errors, the genomic DNA
was resequenced by Illumina HiSeq 2000 (Genome Technology
Access Center [GTAC], Washington University, St. Louis, MO) by
collecting 50-bp single-end reads, generating a total of 9,574,454
reads (403,593,696 nucleotides), reaching a depth of 222-fold genome coverage. Illumina data were aligned to the reference HSC5
scaffold sequence using DNAStar SeqMan NGen 4.0.0 (DNAStar)
to generate a final consensus sequence. The HSC5 genome is composed of 1,818,351 bp, with an average G⫹C content of 38.5%.
Nucleotide sequence accession number. The complete wholegenome sequence of S. pyogenes strain HSC5 has been deposited in
the NCBI under the accession no. CP006366.
ACKNOWLEDGMENTS
This work was supported by Public Health Service grants no. AI046433
and AI064721 from the NIH.
We thank Shaukat Rangwala and William Curtiss at MOgene LC for
providing their technical expertise. We also thank the Genome Technology Access Center in the Department of Genetics at the Washington University School of Medicine for help with genomic analysis. The Center
is partially supported by NCI Cancer Center Support grant no. P30
CA91842 to the Siteman Cancer Center and by ICTS/CTSA grant no.
UL1RR024992 from the National Center for Research Resources
(NCRR), a component of the National Institutes of Health (NIH), and the
NIH Road map for Medical Research.
This publication is solely the responsibility of the authors and does not
necessarily represent the official views of NCRR or NIH.

REFERENCES
1. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470 –511.
2. Hanski E, Horwitz PA, Caparon MG. 1992. Expression of protein F, the
fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains promotes their adherence to
respiratory epithelial cells. Infect. Immun. 60:5119 –5125.

Genome Announcements

genomea.asm.org 1

Port et al.

3. Neely MN, Pfeifer JD, Caparon M. 2002. Streptococcus-zebrafish model
of bacterial pathogenesis. Infect. Immun. 70:3904 –3914.
4. Brenot A, King KY, Janowiak B, Griffith O, Caparon MG. 2004. Contribution of glutathione peroxidase to the virulence of Streptococcus pyogenes. Infect. Immun. 72:408 – 413.
5. Watson ME, Jr, Nielsen HV, Hultgren SJ, Caparon MG. 2013. Murine
vaginal colonization model for investigating asymptomatic mucosal carriage of Streptococcus pyogenes. Infect. Immun. 81:1606 –1617.
6. Carroll RK, Musser JM. 2011. From transcription to activation: how
group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine
protease production. Mol. Microbiol. 81:588 – 601.
7. Kang SO, Caparon MG, Cho KH. 2010. Virulence gene regulation by
CvfA, a putative RNase: the CvfA-enolase complex in Streptococcus pyogenes links nutritional stress, growth-phase control, and virulence gene
expression. Infect. Immun. 78:2754 –2767.

2 genomea.asm.org

8. Cho KH, Caparon MG. 2008. tRNA modification by GidA/MnmE is
necessary for Streptococcus pyogenes virulence: a new strategy to make live
attenuated strains. Infect. Immun. 76:3176 –3186.
9. Loughman JA, Caparon MG. 2006. A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. EMBO J. 25:5414 –5422.
10. Lyon WR, Gibson CM, Caparon MG. 1998. A role for trigger factor and
an rgg-like regulator in the transcription, secretion and processing of the
cysteine proteinase of Streptococcus pyogenes. EMBO J. 17:6263– 6275.
11. Rosch JW, Vega LA, Beyer JM, Lin A, Caparon MG. 2008. The signal
recognition particle pathway is required for virulence in Streptococcus pyogenes. Infect. Immun. 76:2612–2619.
12. Rosch J, Caparon M. 2004. A microdomain for protein secretion in
Gram-positive bacteria. Science 304:1513–1515.
13. Caparon MG, Scott JR. 1991. Genetic manipulation of pathogenic streptococci. Methods Enzymol. 204:556 –586.

Genome Announcements

July/August 2013 Volume 1 Issue 4 e00612-13

